Location: Home
  • search
  • go
  • Relate News
  • 1/30/2026AstraZeneca Expands Obesity Pipeline Through $18.5B CSPC Collaboration
  • 1/20/2026Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk Seen as Likely Cus...
  • 1/1/2026China's Supreme Court Upholds Semaglutide Patent, Strengthening IP Pro...
  • 1/1/2026Eli Lilly Slashes Mounjaro Price in China, Sparking Fierce Weight-Loss...
  • 12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry
  • 12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
  • 12/8/2025CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...
  • 11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...
  • 11/18/2025India and China Explore Reverse-Trade Model for Pharmaceuticals
  • 11/12/2025Indian Pharma Firms Secure Key Wins in China's Latest VBP Round
  • 11/4/2025CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...
  • 10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...
  • 10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)
  • 10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...
  • 10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
  • 9/29/2025China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
  • 9/19/2025China's Sharp API Price Cuts Jeopardize India's Self-Reliance Push
  • 9/19/2025China Produces Dozens of Drugs Below Market Price – U.S. Faces Strate...
  • 9/19/2025Obesity in China (The Lancet)
  • 9/15/2025Hengrui Files PCT Patent for Novel Amylin Analog with Dual Receptor Ac...
  • 9/13/2025CDE Releases First Technical Guidelines for GLP-1 Drugs
  • 9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
  • 8/21/2025Novo Nordisk Meets NHC Minister to Strengthen Collaboration
  • 8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...
  • 8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
  • 8/1/2025India Moves to Set Minimum Import Prices to Protect Pharma Sector from...
  • 7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/15/2025Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
  • 7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
  • Page:1/44 Total number of articles:1292: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group